We hypothesized that antagonizing ZDHHC5-mediated palmitoylation on the cytoplasmic tail of SSTR5 may represent a more efficacious approach for the treatment of pancreatic cancer. Here, SSTR5 is linked to familial pancreatic carcinoma.